BRIEF COMMUNICATION
The brain tumor stem cell hypothesis proposes the existence of multipotent glioma cells of origin that are characterized by the expression of stem cell markers and by the capacity for self-renewal, multilineage differentiation, and reestablishment of tumors after transplantation ( 1 -5 ) . An implication of the brain tumor stem cell model is that brain tumor stem cells are resistant to radiation and chemotherapy and may therefore be responsible for tumor recurrence ( 6 , 7 ) . Because adenoviral proteins can completely overcome the molecular machinery of the infected cell, we hypothesized that Delta-24-RGD, an oncolytic adenovirus with enhanced tropism to glioma cells and selective replication in cancer cells with an abnormal Rb pathway ( 8 , 9 ) , may act as a potent therapeutic agent to target brain tumor stem cells and prevent them from developing resistance to other forms of therapy. However, adenoviral receptor expression, infectibility, the susceptibility to adenoviral replication, as well as the characteristics of adenovirus-mediated cell death have not previously been examined in cancer stem cells.
In this study, we isolated neurosphereforming cells from four fresh surgical specimens of glioblastoma multiforme ( 3 ) ( Fig. 1, A ) . These cells exhibited the in vitro stem cell characteristics of extensive self-renewal (more than fi ve passages in culture) and the ability to differentiate to neurons and astrocytes ( Supplementary  Fig. 1 , available online). Flow cytometric analyses showed that 20% -80% of the cells expressed the neural stem cell protein CD133, which was recently identifi ed as a potential brain tumor stem cell marker in brain cancer ( 1 ) and in other solid tumors ( 10 , 11 ) ( Fig. 1, A ) . When clonally derived, these cells initiated new tumors when transplanted into the basal ganglia of immunodeficient mice ( Supplementary Fig. 2 , available online). Because Delta-24-RGD is targeted to Rb-defi cient cells ( 8 , 9 ) , we examined the levels of Rb and p16INK4a proteins, whose expression is mutually exclusive in glioblastoma multiforme ( 12 , 13 ) , in brain tumor stem cells. As reported for glioblastoma multiforme, immunoblotting analyses showed that the expression of either Rb or p16 protein was absent in these cell lines ( Fig. 1, B ) . Next, using fl ow cytometric analysis, we demonstrated that the cell lines expressed high levels (>50% positive cells) of coxsacki e -adenovirus receptor, the main adenoviral receptor required for virus attachment ( 14 ) , and/or Arg-Gly-Asp (RGD) -recognizing integrins ␣ v ␤ 3 and ␣ v ␤ 5 for virus internalization ( 15 ) ( Fig. 1, C ) . Consequently, the four glioma stem cell lines were susceptible to adenoviral infection ( Supplementary Fig. 3 , A, available online). Accordingly, treatment of the cell lines with Delta-24-RGD resulted in a drastic reduction in cell viability, and at 6 days after viral infection, the dose inducing 50% cell death (ID50) was less than 2 pfu/cell in the majority of the cell lines, as assessed by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay ( Fig. 1, D ) . As expected, pre treatment with Rb protein resulted in res cue of the viability of Delta-24-RGD -infected cells that was due to the restriction of an effi cient replication phenotype ( Fig. 1, E and F ; Supplementary  Fig. 3 , B, available online).
The pathways involved in adenovirusmediated cell death remain unclear. Here, we showed that Delta-24-RGD induced the formation of acidic vesicular organelles in the four cell lines ( P <.001) ( Fig. 2, A ; Supplementary Fig. 4 , A, available online). The Delta-24-RGDinduced acidic vesicular organelles were further confirmed by the dramatic change in the ratio of the cytosolic LC3-I to membrane-bound LC3-II ( Supplementary Fig. 4 , B, available online), a modification that is essential for the formation of autophagosomes ( 16 ) , in the treated cells. These data were consistent with a previous report showing adenovirus-induced autophagy in two established glioma cell lines ( 17 ) . The observation of increased levels of biochemical markers and cellular acidic vesicular organelles was strongly supported by the direct demonstration of cytoplasmic autophagic vacuoles in cells treated with Delta-24-RGD using electron microscopy ( Fig. 2, B ) . To examine the activation of proautophagic signaling by Delta-24-RGD infection, we first examined the protein levels of beclin1, a type III PI3 kinase -interacting protein that participates in the induction of autophagy ( 18 ) . Western blot analyses showed no differences in the levels of beclin1 in treated versus untreated cells ( Supplementary Fig. 4 , B, available online). We next analyzed the protein levels of Atg5, a key molecule in the conversion of LC3-I to -II and therefore required for autophagosome formation and autophagic cell death ( 19 ) , during the Delta-24-RGD replication cycle. We observed a remarkable induction of endogenous Atg5 expression that was noticeable by 48 hours after treatment and was increased by six-to eightfold 72 hours after the treatment, the latest time point examined ( Fig. 2, C ; Supplementary  Fig. 4 , B, available online). The timing of Atg5 expression suggested that activation might link Delta-24-RGD -mediated cell lysis to autophagic cell death.
We next examined the anti-tumor efficacy of Delta-24-RGD in intracranial xenografts that were derived from MDNSC11 cells in athymic mice. The mean survival time of control-treated MDNSC11-glioma -bearing mice was 38.5 days (95% confidence interval [CI] = 35.6 to 41.4 days), in contrast to a mean survival time of 66.3 days (95% CI = 55.2 to 77.3 days, the largest observed analysis time is censored, the mean is underestimated) in mice treated with Delta-24-RGD (difference = 27.8 days, 95% CI = 19.5 to 35.9 days; P <.001) ( Fig. 2, D ) with two of eight (25%) mice remaining alive without noticeable neurologic deficits until they were killed at day 92 ( Fig. 2, D ) . Microscopic examination of the brain tissues of control mice with MDNSC11 xenografts revealed highly infiltrative tumors that recapitulated the histopathology of glioblastomas including hypercellularity, hypervascularity, and necrotic areas surrounded by cells in a pseudopalisading distribution ( Supplementary Fig. 2 , available online). Immunohistochemical staining of the tumor from the Delta-24-RGD -treated group revealed the expression of E1A and hexon indicating efficient adenoviral infection and replication in vivo ( Supplementary Fig. 5 , available online). Importantly, immunofluorescence analyses identified high levels of expression of the proautophagic protein Atg5 ( Fig. 2,  E ). Atg5 colocalized with fiber protein and displayed a pattern of expression that clearly defined a tumor zone immediately adjacent to the necrosis area ( Fig. 2, E ) . No other area in the tumor or any area of untreated tumors was positive for Atg5 (data not shown). Therefore, Atg5 appears to be useful to identify the adenoviral wave front of spread and may be used as a cellular indicator of viral activity and a surrogate marker of the antiglioma effect.
In summary, our results show for the fi rst time, to our knowledge, that brain tumor stem cells are susceptible to adenovirus-mediated cell death via autophaghy in vitro and in vivo. Our data are important because brain tumor stem cells are the driving force sustaining tumor growth ( 1 , 3 ) , and therefore developing therapies to target the brain tumor stem cells should be a more effective strategy than conventional treatments. We reported previously that Delta-24-RGD displays effi cacious anti-glioma activity in the models based on established malignant glioma cell lines ( 9 ) . Together, our previous study and this study indicate that Delta-24-RGD effi ciently eliminates both brain tumor stem cells and tumor mass cell populations in gliomas. An alternative theory to the cancer stem cell model hypothesizes that mutant dedifferentiated astrocytes are responsible for the emergence and phenotype of high-grade gliomas ( 20 ) . Nevertheless, despite the origin of these tumor-initiating cells, the resulting phenotype of the cancer cell is probably similar ( 20 ) , and the universal disruption of the Rb pathway renders them susceptible to Delta-24-RGD ( Fig. 1, B ; 8,9,20) . Furthermore, the in vivo assessment of adenovirus-induced autophagy may be a useful way to monitor oncolytic adenovirus effi cacy in future clinical trials.
CONTEXT AND CAVEATS

Prior knowledge
To achieve long-term remission after treatment for brain cancer, it is necessary to eradicate brain tumor stem cells that are resistant to radiation and chemotherapy.
Study design
The therapeutic potential of oncolytic adenovirus Delta-24-RGD targeted to brain tumor cells was tested in vitro using cell lines with stem cell properties that were derived from gliobastoma multiforme tumors and in vivo using a mouse xenograft tumor model.
Contribution
The four cell lines were efficiently infected with an oncolytic adenovirus Delta-24-RGD, which induced autophagic cell death. Mice carrying xenograft tumors that were derived from one of the cell lines survived longer after treatment with Delta-24-RGD than with an inactivated form of the virus.
Implications
Adenovirus-mediated autophagic cell death can be induced in brain tumor cells with properties of stem cells.
Limitations
It is unclear how similar the cell lines developed in this study are to the brain tumor stem cells that exist in human brain cancer or whether the oncolytic adenovirus developed in this study would be efficacious and safe in humans. . B ) Expression of Rb protein (pRb) and p16INK4a (p16) protein in the cell lines. Normal human astrocytes (NHAs) were purchased from Cambrex Bio Science Walkersville, Inc (Walkersville, MD) and maintained in astrocyte growth medium prepared from an AGM-Astroctye Medium BulletKit (Cambrex Bio Science Walkersville, Inc) as instructed by the manufacturer. Western blots were performed as described previously (9) . Briefl y, equal amount of proteins from whole-cell lysates were separated by 8% (pRb) or 15% (p16) sodium dodecyl sulfate -polyacrylamide gel electrophoresis, electrophoretically transferred to nitrocellulose membranes, and the membranes were probed with rabbit polyclonal anti-pRb (1 : 200 dilution), goat polyclonal anti-p16INK4a (1 : 100 dilution), goat polyclonal anti-actin (1 : 1000 dilution) (Santa Cruz Biotechnology), and mouse monoclonal anti -␣ -tubulin (1 : 4000 dilution; Sigma -Aldrich). The protein -antibody complexes were visualized using the enhanced chemiluminescence western blotting detection system (Amersham Pharmacia Biotech, Piscataway, NJ). ␣ -tubulin and actin were used as loading controls. One representative experiment of two is shown. C ) Flow cytometric analysis of ␣ v ␤ 3, ␣ v ␤ 5 integrins and coxsackie -adenovirus receptor (CAR) expression in the cell lines. The analysis was performed as described previously (9) . Dissociated cells (5 × and by pipetting before cell viability was assessed using the MTS assay according to the manufacturer's instructions (Promega Life Science, Madison, MI). The experiments were performed once in triplicate. Data are shown as mean (and 95% CIs) percentage of viable cells relative to that of mock-treated cells (equal to 100%). E ) Effect of pRb restoration on the Delta-24-RGD -mediated cytotoxicity in MDNSC23 cells. The cells were infected with replication-defi cient adenovirus expressing Rb protein, AdRb, or the control E1A-deleted virus AdCMV at 150 pfu/cell, as previously reported (9) . Forty-eight hours later, cells were plated (2 × 10 4 per well) in 96-well plates and infected with Delta-24-RGD or wildtype adenovirus (Adwt) at the indicated doses. Six days later, cell viability was determined using the MTS assay as described in ( D ). The experiments were performed once in triplicate. Data are shown as the mean (and 95% CIs) percentage of viable cells relative to that of mocktreated cells (equal to 100%). At viral dosages of 2 and 6 pfu/cell, the Rb-mediated rescue of the cytotoxicity induced by Delta-24-RGD treatment is statistically signifi cantly greater than the Rb-mediated rescue in cells treated with Adwt (* P = .01, # P = .03, two-tailed Student's t -test). F ) Effect of pRb restoration on the replication of Delta-24-RGD in MDNSC23. Cells were infected with AdRb or control virus AdCMV at 150 pfu/cell, as described in ( E ). Forty-eight hours later, the cells were infected with Delta-24-RGD or Adwt at 1 pfu/cell. The titers of the viral progenies were determined 72 hours after viral infection using the tissue culture infection dose 50 method, as described previously (9) . Shown are the titers of viral progenies from 1 × 10 5 cells in 1 mL infected with the indicated viruses. The experiments were performed once in triplicate. Means (and 95% CIs) are shown. The Rb-mediated restriction on Delta-24-RGD replication is statistically signifi cantly greater than that on Adwt in MDNSC23 cells (* P = .009, two-tailed Student's t -test). Delta-24-RGD infection. MDNSC11 cells were collected at the indicated time points after Delta-24-RGD infection, and equal amounts of proteins were separated by 10% sodium dodecyl sulfate -polyacrylamide gel electrophoresis. Proteins were electrophoretically transferred to nitrocellulose membranes, and the membranes were probed with rabbit polyclonal anti-Atg5 (1 : 2000 dilution; a kind gift from Dr N. Mizushima, National Institute for Basic Biology, Japan) and goat polyclonal antiactin antibodies. The protein -antibody complexes were visualized as described (in Fig. 1, B ) . Actin was used as a loading control. Data from one representative experiment of two are shown. D ) Kaplan -Meier curves of overall survival of Delta-24-RGD -treated (n = 8) and UV-inactivated (UVi) Delta-24-RGD -treated (n = 6) athymic mice with MDNSC11 intracranial xenografts. Cells (1.0 × 10 6 ) were grafted into the caudate nucleus of the athymic mice using a guide-screw system as previously described (9) . On days 7, 9, and 11 after tumor cell implantation, mice were intratumorally injected with 10 µ L of Delta-24-RGD or UVi-Delta-24-RGD (2.5 × 10 8 pfu). Survival in the two treatment groups was compared using the log-rank test (two-sided). All mouse studies were performed in the veterinary facilities of University of Texas M. D. Anderson Cancer Center in accordance with institutional, state, and federal laws and ethics guidelines for experimental animal care. E ) Viral replication and autophagy in vivo. Immunofl uorescence analysis of viral fi ber and Atg5 proteins expression in the brain of a mouse from the study represented in ( D ) that was treated with Delta-24-RGD and died 59 days after implantation. The paraffi n-embedded section of the mouse brain was double immunostained with mouse monoclonal antibodies specifi c for adenoviral fi ber protein (4D2, 1 : 500 dilution; Lab Vision, Fremont, CA) ( a ) or rabbit polyclonal Atg5 (1 : 200 dilution) ( b ) and then with Texas Red (fi ber) -or Alexa Fluor 488 (Atg5) -conjugated secondary antibodies (1 : 500 dilution; Molecular Probes, Inc, Eugene, OR). Fluorescence staining for fi ber and Atg5 were merged and 4 ′ ,6-diamidino-2-phenylindole, dihydrochloride (DAPI) staining was used to visualize the cell nuclei ( c ). 
